272 related articles for article (PubMed ID: 28009083)
1. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.
Güttsches AK; Brady S; Krause K; Maerkens A; Uszkoreit J; Eisenacher M; Schreiner A; Galozzi S; Mertens-Rill J; Tegenthoff M; Holton JL; Harms MB; Lloyd TE; Vorgerd M; Weihl CC; Marcus K; Kley RA
Ann Neurol; 2017 Feb; 81(2):227-239. PubMed ID: 28009083
[TBL] [Abstract][Full Text] [Related]
2. Chaperones in sporadic inclusion body myositis-Validation of proteomic data.
Güttsches AK; Jacobsen F; Schreiner A; Mertens-Rill J; Tegenthoff M; Marcus K; Vorgerd M; Kley RA
Muscle Nerve; 2020 Jan; 61(1):116-121. PubMed ID: 31644823
[TBL] [Abstract][Full Text] [Related]
3. Gain and loss of extracellular molecules in sporadic inclusion body myositis and polymyositis--a proteomics-based study.
Doppler K; Lindner A; Schütz W; Schütz M; Bornemann A
Brain Pathol; 2012 Jan; 22(1):32-40. PubMed ID: 21672074
[TBL] [Abstract][Full Text] [Related]
4. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
Pinkus JL; Amato AA; Taylor JP; Greenberg SA
Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
[TBL] [Abstract][Full Text] [Related]
5. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
[TBL] [Abstract][Full Text] [Related]
6. Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.
Gang Q; Bettencourt C; Machado PM; Brady S; Holton JL; Pittman AM; Hughes D; Healy E; Parton M; Hilton-Jones D; Shieh PB; Needham M; Liang C; Zanoteli E; de Camargo LV; De Paepe B; De Bleecker J; Shaibani A; Ripolone M; Violano R; Moggio M; Barohn RJ; Dimachkie MM; Mora M; Mantegazza R; Zanotti S; Singleton AB; Hanna MG; Houlden H;
Neurobiol Aging; 2016 Nov; 47():218.e1-218.e9. PubMed ID: 27594680
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis.
Girolamo F; Lia A; Amati A; Strippoli M; Coppola C; Virgintino D; Roncali L; Toscano A; Serlenga L; Trojano M
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):736-49. PubMed ID: 23452291
[TBL] [Abstract][Full Text] [Related]
8. CYLD dysregulation in pathogenesis of sporadic inclusion body myositis.
Yamashita S; Matsuo Y; Tawara N; Hara K; Yamamoto M; Nishikami T; Kawakami K; Zhang X; Zhang Z; Doki T; Ando Y
Sci Rep; 2019 Aug; 9(1):11606. PubMed ID: 31406156
[TBL] [Abstract][Full Text] [Related]
9. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
[TBL] [Abstract][Full Text] [Related]
10. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM
Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370
[TBL] [Abstract][Full Text] [Related]
11. Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.
Tawara N; Yamashita S; Zhang X; Korogi M; Zhang Z; Doki T; Matsuo Y; Nakane S; Maeda Y; Sugie K; Suzuki N; Aoki M; Ando Y
Ann Neurol; 2017 Apr; 81(4):512-525. PubMed ID: 28318044
[TBL] [Abstract][Full Text] [Related]
12. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.
Yamashita S; Kimura E; Tawara N; Sakaguchi H; Nakama T; Maeda Y; Hirano T; Uchino M; Ando Y
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):406-16. PubMed ID: 22860700
[TBL] [Abstract][Full Text] [Related]
13. Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.
Weihl CC; Baloh RH; Lee Y; Chou TF; Pittman SK; Lopate G; Allred P; Jockel-Balsarotti J; Pestronk A; Harms MB
Neuromuscul Disord; 2015 Apr; 25(4):289-96. PubMed ID: 25617006
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Profiling Unravels a Key Role of Specific Macrophage Subtypes in Sporadic Inclusion Body Myositis.
Roos A; Preusse C; Hathazi D; Goebel HH; Stenzel W
Front Immunol; 2019; 10():1040. PubMed ID: 31143183
[TBL] [Abstract][Full Text] [Related]
15. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies.
Olivé M; Janué A; Moreno D; Gámez J; Torrejón-Escribano B; Ferrer I
J Neuropathol Exp Neurol; 2009 Mar; 68(3):262-73. PubMed ID: 19225410
[TBL] [Abstract][Full Text] [Related]
16. Effect of Resistance Exercise on Muscle Metabolism and Autophagy in sIBM.
Jeong JH; Yang DS; Koo JH; Hwang DJ; Cho JY; Kang EB
Med Sci Sports Exerc; 2017 Aug; 49(8):1562-1571. PubMed ID: 28333717
[TBL] [Abstract][Full Text] [Related]
17. Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis.
de Camargo LV; de Carvalho MS; Shinjo SK; de Oliveira ASB; Zanoteli E
Biomed Res Int; 2018; 2018():5069042. PubMed ID: 29780824
[TBL] [Abstract][Full Text] [Related]
18. The origins of rimmed vacuoles and granulovacuolar degeneration bodies are associated with the Wnt signaling pathway.
Murata-Shinozaki Y; Takahashi T; Matsubara T; Maruyama H; Izumi Y; Matsumoto M
Neurosci Lett; 2017 Jan; 638():55-59. PubMed ID: 27939356
[TBL] [Abstract][Full Text] [Related]
19. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis.
Kumamoto T; Ueyama H; Tsumura H; Toyoshima I; Tsuda T
Acta Neuropathol; 2004 Jan; 107(1):59-65. PubMed ID: 14513262
[TBL] [Abstract][Full Text] [Related]
20. [Recent progress in diagnosis and pathomechanism of inclusion body myositis].
Aoki M; Suzuki N; Kato M; Warita H
Rinsho Shinkeigaku; 2014; 54(12):1115-8. PubMed ID: 25672724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]